Study of TAVO101 in Healthy Volunteers

Clinical trial NCT05298046 · COMPLETED

Trial details

NCT number: NCT05298046
Sponsor: Tavotek Biotherapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2022-05-11
Primary completion: 2024-06-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.